Screener
AbbVie ABBV Long-Term Debt
Discontinued — last reported Q4 '25
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.
The source filing: AbbVie’s 10-K, filed February 20, 2026.
- Filed
- Feb 20, 2026, 2:38 PM EST
- Fiscal year
- FY2025
- Accession
- 0001551152-26-000008
| as of December 31 (in millions, except share data) | 2025 | 2024 |
|---|---|---|
| Current portion of long-term debt and finance lease obligations | 6,056 | 6,804 |
| Accounts payable and accrued liabilities | 34,734 | 31,945 |
| Total current liabilities | 43,289 | 38,749 |
| Long-term debt and finance lease obligations | 58,941 | 60,340 |
| Deferred income taxes | 2,389 | 2,579 |
| Other long-term liabilities | 32,569 | 30,129 |
| Commitments and contingencies | ||
| Stockholders' equity (deficit) |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is AbbVie's long-term debt?
- AbbVie (ABBV) reported long-term debt of $58.94B in Q4 2025.
- How has AbbVie's long-term debt changed year-over-year?
- AbbVie's long-term debt decreased by 2.3% year-over-year, from $60.34B to $58.94B.
- What is the long-term trend for AbbVie's long-term debt?
- Over 5 years (2020 to 2025), AbbVie's long-term debt has grown at a -5.3% compound annual growth rate (CAGR), from $77.55B to $58.94B.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about AbbVie's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude